Get the Stockscreener App
1.9499
1.01%
-0.0301
Cero Therapeutics Holdings Inc Stock (CERO) Forecast
The Cero Therapeutics Holdings Inc (CERO) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $8.4372, representing a +332.70% increase from the current price of $1.9499. The highest analyst price target is $8.4884, and the lowest is $8.3861.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month CERO Price Target
Average 10.59
(+443.31% Upside)
Is Cero Therapeutics Holdings Inc (CERO) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 33.55 | Neutral |
| STOCH(9,6) | 18.15 | Buy |
| STOCHRSI(14) | 68.55 | Neutral |
| MACD(12,26) | -1.3539 | Buy |
| ADX(14) | 13.88 | Neutral |
| William %R | -85.21 | Buy |
| CCI(14) | -13.05 | Neutral |
Buy: 3
Sell: 0
Neutral: 4
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
2.055
Sell
|
2.159
Sell
|
| MA20 |
2.524
Sell
|
2.9673
Sell
|
| MA50 |
7.439
Sell
|
6.1696
Sell
|
| MA100 |
9.3444
Sell
|
16.64
Sell
|
| MA200 |
32.00
Sell
|
56.59
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, CERO could be considered a Strong Sell, with 17 technical analysis indicators signaling 3 Buy signals, 10 signaling Sell signals and 4 Neutral signals. This might not be a good time to consider opening new positions on CERO, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 33.55 indicates that CERO is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 18.15 indicates that CERO is oversold. This indicates that CERO price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 68.55 indicates that CERO is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 13.88 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -13.05 indicates that CERO is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term CERO price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Cero Therapeutics Holdings Inc financial reports and earnings history, Cero Therapeutics Holdings Inc (CERO) stock could reach $66.35 by 2030, $146.19 by 2040 and $175.02 by 2050. See the projected annual prices until 2050 of the Cero Therapeutics Holdings Inc stock below:
- Cero Therapeutics Holdings Inc (CERO) is expected to reach an average price of $134.62 in 2035, with a high prediction of $133.38 and a low estimate of $44.80. This indicates an $6,804% rise from the last recorded price of $1.9499.
- Cero Therapeutics Holdings Inc (CERO) stock is projected to chart a bullish course in 2040, with an average price target of $117.33, representing an $5,917% surge from its current level. The forecast ranges from a conservative $117.37 to a sky-high $146.19.
- Our analysts predict Cero Therapeutics Holdings Inc (CERO) to jump 11,276% by 2045, soaring from $222.07 to an average price of $221.82, potentially reaching $259.18. While $222.07 is the low estimate, the potential upside is significant.
- Cero Therapeutics Holdings Inc (CERO) stock is expected to climb by 2050, reaching an average of $126.01, a $6,362% jump from its current level. However, a wide range of estimates exists, with high and low targets of $175.02 and $126.06, respectively, highlighting the market's uncertainty.
Cero Therapeutics Holdings Inc Stock (CERO) Year by Year Forecast
Cero Therapeutics Holdings Inc Stock (CERO) Price Forecast for 2025
Cero Therapeutics Holdings Inc Stock (CERO) is expected to reach an average price of $10.02 in 2025, with a high prediction of $17.94 and a low estimate of $2.093. This indicates an +413.71% rise from the last recorded price of $1.9499.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| March, 2025 | $6.8861 | $8.3861 | $8.4884 | +253.15% |
| April, 2025 | $5.6012 | $5.6512 | $6.6951 | +187.26% |
| May, 2025 | $4.0438 | $3.2473 | $4.8404 | +107.39% |
| June, 2025 | $11.45 | $11.70 | $11.54 | +487.15% |
| July, 2025 | $8.3503 | $8.3903 | $9.2314 | +328.24% |
| August, 2025 | $5.2454 | $5.2954 | $7.0965 | +169.01% |
| September, 2025 | $15.37 | $4.4017 | $14.71 | +688.35% |
| October, 2025 | $10.07 | $11.59 | $13.93 | +416.68% |
| November, 2025 | $7.6289 | $7.6689 | $8.9418 | +291.25% |
| December, 2025 | $18.43 | $5.556 | $17.94 | +845.00% |
Cero Therapeutics Holdings Inc Stock (CERO) Price Forecast for 2026
The predicted value for Cero Therapeutics Holdings Inc (CERO) in 2026 is set at an average of $17.35. Estimates vary from a peak of $27.98 to a trough of $6.7103, indicating an +789.54% surge from the present price of $1.9499.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $14.48 | $14.54 | $16.81 | +642.85% |
| February, 2026 | $10.21 | $10.30 | $12.00 | +423.51% |
| March, 2026 | $22.42 | $6.7103 | $21.18 | +1,050% |
| April, 2026 | $18.14 | $18.29 | $21.17 | +830.32% |
| May, 2026 | $12.98 | $13.03 | $16.15 | +565.80% |
| June, 2026 | $9.6976 | $7.8647 | $11.53 | +397.34% |
| July, 2026 | $20.43 | $21.93 | $24.58 | +947.81% |
| August, 2026 | $16.42 | $16.46 | $19.38 | +742.22% |
| September, 2026 | $11.75 | $9.019 | $14.48 | +502.51% |
| October, 2026 | $25.86 | $26.11 | $27.98 | +1,226% |
| November, 2026 | $18.84 | $20.36 | $21.91 | +866.10% |
| December, 2026 | $11.88 | $11.93 | $16.42 | +509.30% |
Cero Therapeutics Holdings Inc Stock (CERO) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Cero Therapeutics Holdings Inc (CERO) is $25.88, with a high forecast of $41.58 and a low forecast of $10.17. This indicates an +1,227% increase from the last price of $1.9499.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $30.64 | $10.17 | $31.38 | +1,472% |
| February, 2027 | $23.94 | $24.00 | $28.34 | +1,128% |
| March, 2027 | $15.13 | $15.17 | $20.76 | +675.84% |
| April, 2027 | $35.51 | $11.33 | $34.78 | +1,721% |
| May, 2027 | $28.29 | $28.44 | $32.92 | +1,351% |
| June, 2027 | $18.57 | $18.66 | $25.60 | +852.40% |
| July, 2027 | $39.42 | $12.48 | $38.18 | +1,922% |
| August, 2027 | $31.27 | $32.77 | $37.30 | +1,504% |
| September, 2027 | $22.21 | $22.26 | $29.52 | +1,039% |
| October, 2027 | $16.76 | $13.64 | $19.89 | +759.78% |
| November, 2027 | $37.38 | $37.63 | $41.58 | +1,817% |
| December, 2027 | $26.51 | $26.55 | $32.06 | +1,260% |
Cero Therapeutics Holdings Inc Stock (CERO) Price Forecast for 2028
In 2028, Cero Therapeutics Holdings Inc (CERO) is projected to reach an average price of $34.99, with a high projection of $55.18 and a low estimate of $14.79. This indicates an +1,694% rise from the last price of $1.9499.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $17.19 | $17.24 | $23.70 | +781.54% |
| February, 2028 | $42.86 | $14.79 | $44.98 | +2,098% |
| March, 2028 | $29.79 | $31.31 | $39.87 | +1,428% |
| April, 2028 | $21.13 | $21.17 | $26.51 | +983.51% |
| May, 2028 | $45.92 | $15.95 | $48.38 | +2,255% |
| June, 2028 | $35.76 | $35.82 | $42.75 | +1,734% |
| July, 2028 | $25.26 | $25.35 | $31.71 | +1,196% |
| August, 2028 | $51.64 | $17.10 | $51.78 | +2,549% |
| September, 2028 | $40.97 | $41.12 | $48.20 | +2,001% |
| October, 2028 | $29.59 | $29.64 | $37.42 | +1,418% |
| November, 2028 | $56.42 | $18.25 | $55.18 | +2,793% |
| December, 2028 | $44.81 | $46.31 | $53.44 | +2,198% |
Cero Therapeutics Holdings Inc Stock (CERO) Price Forecast for 2029
The 2029 price forecast for Cero Therapeutics Holdings Inc Stock (CERO) is $44.09 on average, with a high prediction of $68.78 and a low estimate of $19.41. This represents an +2,161% increase from the previous price of $1.9499.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $31.44 | $31.49 | $42.20 | +1,512% |
| February, 2029 | $23.83 | $19.41 | $28.26 | +1,122% |
| March, 2029 | $51.79 | $52.04 | $58.58 | +2,556% |
| April, 2029 | $38.56 | $40.08 | $44.74 | +1,877% |
| May, 2029 | $23.82 | $23.87 | $34.58 | +1,122% |
| June, 2029 | $58.14 | $20.56 | $61.98 | +2,881% |
| July, 2029 | $45.21 | $45.27 | $54.28 | +2,219% |
| August, 2029 | $28.63 | $28.67 | $40.48 | +1,368% |
| September, 2029 | $64.55 | $21.72 | $65.38 | +3,211% |
| October, 2029 | $47.57 | $47.63 | $60.42 | +2,340% |
| November, 2029 | $33.62 | $33.71 | $42.67 | +1,624% |
| December, 2029 | $70.02 | $22.87 | $68.78 | +3,491% |
Cero Therapeutics Holdings Inc Stock (CERO) Price Forecast for 2030
Cero Therapeutics Holdings Inc Stock (CERO) is expected to reach an average price of $51.50 in 2030, with a high forecast of $78.98 and a low forecast of $24.03. This signifies an +2,541% surge from the last price of $1.9499.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $53.65 | $53.80 | $66.35 | +2,651% |
| February, 2030 | $38.82 | $38.87 | $49.24 | +1,891% |
| March, 2030 | $29.49 | $24.03 | $34.95 | +1,412% |
| April, 2030 | $63.32 | $63.57 | $72.18 | +3,147% |
| May, 2030 | $44.68 | $44.72 | $54.88 | +2,191% |
| June, 2030 | $29.13 | $29.18 | $40.31 | +1,394% |
| July, 2030 | $66.20 | $25.18 | $75.58 | +3,295% |
| August, 2030 | $49.51 | $51.03 | $57.42 | +2,439% |
| September, 2030 | $34.63 | $34.67 | $44.67 | +1,676% |
| October, 2030 | $73.41 | $26.33 | $78.98 | +3,665% |
| November, 2030 | $57.03 | $57.09 | $68.68 | +2,825% |
| December, 2030 | $40.31 | $40.40 | $51.43 | +1,967% |
0.43%
3.18%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):